About
Minicircle develops non-viral plasmid gene therapies (for example, follistatin) administered via subcutaneous injection at licensed partner clinics to support muscle mass, body composition, and markers of aging; its therapies are investigational and offered through international clinical partners.
Explore Minicircle's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.